Clinical Trial: A Phase II Clinical Study to Evaluate the Efficacy and Safety of YKYY018 for Inhalation Solution

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07808268) titled 'A Phase II Clinical Study to Evaluate the Efficacy and Safety of YKYY018 for Inhalation Solution' on Sept. 02.

Brief Summary: A phase II clinical study to evaluate the efficacy and safety of YKYY018 for inhalation solution in adult participants with respiratory syncytial virus infection

Study Start Date: Oct. 10

Study Type: INTERVENTIONAL

Condition: Respiratory Syncytial Virus (RSV)

Intervention: DRUG: YKYY018 for Inhalation Solution

nebulized inhalation, QD or Q2D of the corresponding dose of YKYY018 for inhalation solution

DRUG: YKYY018 Placebo

nebulized inhalation, QD or Q2D of the corresponding dose of YKYY018 placebo ...